[{"NetIncomeLoss_1_Q2_USD":47000000.0,"AssetsCurrent_0_Q2_USD":4194000000.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_1_Q2_USD":62000000.0,"GoodwillImpairmentLoss_1_Q2_USD":0.0,"Depreciation_2_Q2_USD":75000000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-455000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q2_USD":6000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2_Q2_USD":15000000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":1000000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":378000000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":27000000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":477000000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q2_USD":305000000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":0.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":58.21,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":14000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":0.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":1000000.0,"OtherNoncashIncomeExpense_2_Q2_USD":12000000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":549000000.0,"ShareBasedCompensation_2_Q2_USD":55000000.0,"Assets_0_Q2_USD":7248000000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":1322000000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":261000000.0,"EquitySecuritiesFvNi_0_Q2_USD":176000000.0,"TreasuryStockValue_0_Q2_USD":3389000000.0,"LongTermDebtCurrent_0_Q2_USD":503000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":1000000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_1_Q2_USD":11000000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_2_Q2_USD":40000000.0,"ContractWithCustomerLiability_0_Q2_USD":196000000.0,"DerivativeGainLossOnDerivativeNet_2_Q2_USD":-107000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":177000000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":451000000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":547000000.0,"AccountsReceivableGrossCurrent_0_Q2_USD":389000000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":34000000.0,"ProductWarrantyAccrual_0_Q2_USD":10000000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":8000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":122000000.0,"AccountsReceivableNetCurrent_0_Q2_USD":385000000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":73000000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":58000000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-41000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":148000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":148000000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":118000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-4000000.0,"EarningsPerShareBasic_1_Q2_USD":0.32,"EarningsPerShareBasic_2_Q2_USD":1.5,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":58.21,"ResearchAndDevelopmentExpense_1_Q2_USD":155000000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":311000000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":23000000.0,"ShortTermInvestments_0_Q2_USD":1498000000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":218000000.0,"EquityMethodInvestments_0_Q2_USD":79000000.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"PaymentsForDerivativeInstrumentInvestingActivities_2_Q2_USD":132000000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":9000000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":30000000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":681000000.0,"OtherAssetsNoncurrent_0_Q2_USD":552000000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":15000000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-13000000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":55000000.0,"CommonStockValue_0_Q2_USD":2000000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":229000000.0,"ProductWarrantyAccrualPayments_1_Q2_USD":4000000.0,"ProductWarrantyAccrualPayments_2_Q2_USD":9000000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0_Q2_USD":525000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-334000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.716,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.357,"RevenueRemainingPerformanceObligation_0_Q2_USD":784000000.0,"IncreaseDecreaseInInventories_2_Q2_USD":75000000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":13000000.0,"TreasuryStockSharesAcquired_2_Q2_shares":1100000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":95000000.0,"CostOfRevenue_1_Q2_USD":205000000.0,"CostOfRevenue_2_Q2_USD":445000000.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_1_Q2_shares":0.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2_Q2_shares":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":147000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":147000000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":287000000.0,"LiabilitiesCurrent_0_Q2_USD":1115000000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":147000000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":66000000.0,"MarketableSecuritiesUnrealizedGainLoss_2_Q2_USD":69000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":16000000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":38000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":165000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":342000000.0,"Goodwill_0_Q2_USD":894000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":521000000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":18000000.0,"AccountsPayableCurrent_0_Q2_USD":135000000.0,"NonoperatingIncomeExpense_1_Q2_USD":69000000.0,"NetIncomeLoss_2_Q2_USD":220000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":890000000.0,"AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_0_Q2_USD":797000000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":48000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":4563000000.0,"AdditionalPaidInCapital_0_Q2_USD":3649000000.0,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":-47000000.0,"NonoperatingIncomeExpense_2_Q2_USD":57000000.0,"GrossProfit_1_Q2_USD":428000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":156000000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":68000000.0,"LongTermDebtNoncurrent_0_Q2_USD":659000000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":106000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":1770000000.0,"InterestExpense_1_Q2_USD":11000000.0,"InterestExpense_2_Q2_USD":22000000.0,"GrossProfit_2_Q2_USD":1047000000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":38000000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":106000000.0,"EarningsPerShareDiluted_1_Q2_USD":0.32,"AllocatedShareBasedCompensationExpense_2_Q2_USD":55000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":164000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":7248000000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":56.33,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":153000000.0,"InvestmentIncomeInterest_1_Q2_USD":7000000.0,"InvestmentIncomeInterest_2_Q2_USD":21000000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":17000000.0,"InventoryNet_0_Q2_USD":435000000.0,"ProductWarrantyAccrualWarrantiesIssued_1_Q2_USD":2000000.0,"ProductWarrantyAccrualWarrantiesIssued_2_Q2_USD":5000000.0,"OperatingIncomeLoss_1_Q2_USD":96000000.0,"OperatingIncomeLoss_2_Q2_USD":285000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":633000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":1492000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-3000000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":330000000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":19000000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":48000000.0,"OperatingExpenses_2_Q2_USD":762000000.0,"EarningsPerShareDiluted_2_Q2_USD":1.49,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-190000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-272000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":4287000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":10000.0,"NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_1_Q2_USD":47000000.0,"TaxesPayableCurrent_0_Q2_USD":44000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":10000.0,"CashDivestedFromDeconsolidation_2_Q2_USD":0.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":1304000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":4000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":79000000.0,"GoodwillAcquiredDuringPeriod_2_Q2_USD":70000000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":230000000.0,"ProfitLoss_1_Q2_USD":47000000.0,"ProfitLoss_2_Q2_USD":220000000.0,"OperatingExpenses_1_Q2_USD":332000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":55000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":229000000.0,"Ticker":"ILMN","CIK":"1110803","name":"ILLUMINA, INC.","OfficialName":"Illumina Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"53766364980.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"SP500","filed":"20200807"}]